- Home
- NKTX vs CEP Comparison
NKTX vs CEP Comparison
Compare NKTX & CEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- CEP
- Stock Information
- Founded
- NKTX 2015
- CEP 2020
- Country
- NKTX United States
- CEP United States
- Employees
- NKTX N/A
- CEP N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- CEP
- Sector
- NKTX Health Care
- CEP
- Exchange
- NKTX Nasdaq
- CEP NYSE
- Market Cap
- NKTX 123.5M
- CEP 131.6M
- IPO Year
- NKTX 2020
- CEP 2024
- Fundamental
- Price
- NKTX $1.74
- CEP $40.33
- Analyst Decision
- NKTX Strong Buy
- CEP
- Analyst Count
- NKTX 6
- CEP 0
- Target Price
- NKTX $14.80
- CEP N/A
- AVG Volume (30 Days)
- NKTX 422.6K
- CEP 3.4M
- Earning Date
- NKTX 05-14-2025
- CEP 01-01-0001
- Dividend Yield
- NKTX N/A
- CEP N/A
- EPS Growth
- NKTX N/A
- CEP N/A
- EPS
- NKTX N/A
- CEP 0.25
- Revenue
- NKTX N/A
- CEP N/A
- Revenue This Year
- NKTX N/A
- CEP N/A
- Revenue Next Year
- NKTX N/A
- CEP N/A
- P/E Ratio
- NKTX N/A
- CEP $159.75
- Revenue Growth
- NKTX N/A
- CEP N/A
- 52 Week Low
- NKTX $1.31
- CEP $9.99
- 52 Week High
- NKTX $8.23
- CEP $59.75
- Technical
- Relative Strength Index (RSI)
- NKTX 45.11
- CEP N/A
- Support Level
- NKTX $1.70
- CEP N/A
- Resistance Level
- NKTX $1.82
- CEP N/A
- Average True Range (ATR)
- NKTX 0.10
- CEP 0.00
- MACD
- NKTX -0.01
- CEP 0.00
- Stochastic Oscillator
- NKTX 18.82
- CEP 0.00
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About CEP CANTOR EQUITY PARTNERS INC
Cantor Equity Partners Inc is a blank check company.